New Oral Anticoagulants Are Not Superior to Warfarin in Secondary Prevention of Stroke or Transient Ischemic Attacks, but Lower the Risk of Intracranial Bleeding: Insights from a Meta-Analysis and Indirect Treatment Comparisons

PURPOSE: Patients with Atrial Fibrillation (AF) and prior stroke are classified as high risk in all risk stratification schemes. A systematic review and meta-analysis was performed to compare the efficacy and safety of New Oral Anticoagulants (NOACs) to warfarin in patients with AF and previous stro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sardar, Partha, Chatterjee, Saurav, Wu, Wen-Chih, Lichstein, Edgar, Ghosh, Joydeep, Aikat, Shamik, Mukherjee, Debabrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808395/
https://www.ncbi.nlm.nih.gov/pubmed/24204920
http://dx.doi.org/10.1371/journal.pone.0077694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808395/
https://www.ncbi.nlm.nih.gov/pubmed/24204920
http://dx.doi.org/10.1371/journal.pone.0077694

Ejemplares similares